# Optimisation of Controlled Human Malaria Infection Using Sporozoites Administered by Needle and Syringe

> **NCT01465048** · NA · COMPLETED · sponsor: **University of Oxford** · enrollment: 18 (actual)

## Conditions studied

- Malaria
- Plasmodium Falciparum

## Interventions

- **BIOLOGICAL:** Plasmodium falciparum sporozoites 2sites
- **BIOLOGICAL:** Plasmodium falciparum sporozoites 1 site
- **BIOLOGICAL:** Plasmodium falciparum sporozoites 1site

## Key facts

- **NCT ID:** NCT01465048
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2012-02
- **Final completion:** 2013-02
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2013-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01465048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01465048, "Optimisation of Controlled Human Malaria Infection Using Sporozoites Administered by Needle and Syringe". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01465048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*